We demonstrate that pharmacological strategies of blocking either the IL-1 receptor or NLRP3 activation were both very effective in reversing QTc prolongation and attenuating the vulnerability to Caff/Dobu induced arrhythmias in our experimental DM model. This evidence concerns the gene NLRP3 and diabetes mellitus.